Fintel reports that on November 6, 2025, BTIG maintained coverage of CareDx (NasdaqGM:CDNA) with a Buy recommendation. Analyst Price Forecast Suggests 38.84% Upside As of October 30, 2025, the average ...

CareDx (CDNA) has flipped to profitability for the first time, with net profit margins turning positive and earnings now forecast to soar 80.2% per year. This growth rate far outpaces the company’s ...

CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions ...

For the quarter ended September 2025, CareDx (CDNA) reported revenue of $100.06 million, up 20.7% over the same period last year. EPS came in at $0.28, compared to $0.14 in the year-ago quarter. The ...

CareDx (CDNA) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.14 per share a year ago. These figures are ...

AMD outlined its next steps in the AI and HPC accelerator market at its 2025 Financial Analyst Day, revealing the Instinct MI400 series based on the CDNA 5 architecture.